BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10869054)

  • 1. Physiological, pharmacological and neurohormonal assessment of autonomic function in progressive supranuclear palsy.
    Kimber J; Mathias CJ; Lees AJ; Bleasdale-Barr K; Chang HS; Churchyard A; Watson L
    Brain; 2000 Jul; 123 ( Pt 7)():1422-30. PubMed ID: 10869054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities of rate-corrected QT intervals in Parkinson's disease-a comparison with multiple system atrophy and progressive supranuclear palsy.
    Deguchi K; Sasaki I; Tsukaguchi M; Kamoda M; Touge T; Takeuchi H; Kuriyama S
    J Neurol Sci; 2002 Jul; 199(1-2):31-7. PubMed ID: 12084439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine.
    Kimber JR; Watson L; Mathias CJ
    Lancet; 1997 Jun; 349(9069):1877-81. PubMed ID: 9217760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular reflex testing contributes to clinical evaluation and differential diagnosis of Parkinsonian syndromes.
    Holmberg B; Kallio M; Johnels B; Elam M
    Mov Disord; 2001 Mar; 16(2):217-25. PubMed ID: 11295773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy.
    Malkiewicz JJ; Siuda J
    Neurol Neurochir Pol; 2024; 58(2):193-202. PubMed ID: 38148738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of nocturnal blood pressure fall in various extrapyramidal syndromes.
    Schmidt C; Berg D; ; Prieur S; Junghanns S; Schweitzer K; Globas C; Schöls L; Reichmann H; Ziemssen T
    Mov Disord; 2009 Oct; 24(14):2136-42. PubMed ID: 19768815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autonomic cardiovascular reflexes in progressive supranuclear palsy.
    Gutrecht JA
    J Auton Nerv Syst; 1992 Jun; 39(1):29-35. PubMed ID: 1629523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M; Hayashi M; Hirai S
    Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valsalva manoeuvre in patients with different Parkinsonian disorders.
    Schmidt C; Herting B; Prieur S; Junghanns S; Schweitzer K; Globas C; Schöls L; Reichmann H; Berg D; Ziemssen T
    J Neural Transm (Vienna); 2009 Jul; 116(7):875-80. PubMed ID: 19499177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autonomic nervous function in progressive supranuclear palsy--comparison with Parkinson's disease and healthy controls].
    Sasaki I; Takeuchi H; Deguchi K; Yamada A; Nishioka M; Sakamoto H
    Rinsho Shinkeigaku; 1994 Oct; 34(10):975-9. PubMed ID: 7834957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological and clinical assessment of dysautonomia in multiple system atrophy (MSA) and progressive supranuclear palsy (PSP): a comparative study.
    Nojszewska M; Potulska-Chromik A; Jamrozik Z; Janik P; Zakrzewska-Pniewska B
    Neurol Neurochir Pol; 2019; 53(1):26-33. PubMed ID: 30620042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular and neurohormonal responses to i. v. l-arginine in two groups with primary autonomic failure.
    Kimber J; Watson L; Mathias CJ
    J Neurol; 2001 Dec; 248(12):1036-41. PubMed ID: 12013579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive autonomic assessment does not differentiate between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Reimann M; Schmidt C; Herting B; Prieur S; Junghanns S; Schweitzer K; Globas C; Schoels L; Reichmann H; Berg D; Ziemssen T
    J Neural Transm (Vienna); 2010 Jan; 117(1):69-76. PubMed ID: 19763772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive supranuclear palsy is not associated with neurogenic orthostatic hypotension.
    van Gerpen JA; Al-Shaikh RH; Tipton PW; Wszolek ZK; Uitti RJ; Ferman TJ; Dickson DW; Benarroch EE; Singer W; Cutsforth-Gregory JK; Heckman MG; Brushaber DE; Josephs KA; Low PA; Ahlskog JE; Cheshire WP
    Neurology; 2019 Oct; 93(14):e1339-e1347. PubMed ID: 31484717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-four-hour ambulatory blood pressure and heart rate profiles in diagnosing orthostatic hypotension in Parkinson's disease and multiple system atrophy.
    Vichayanrat E; Low DA; Iodice V; Stuebner E; Hagen EM; Mathias CJ
    Eur J Neurol; 2017 Jan; 24(1):90-97. PubMed ID: 27718292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders.
    Yamamoto T; Tateno F; Sakakibara R; Furukawa S; Asahina M; Uchiyama T; Hirano S; Yamanaka Y; Fuse M; Koga Y; Yanagisawa M; Kuwabara S
    PLoS One; 2016; 11(2):e0149278. PubMed ID: 26886104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Numao A; Suzuki K; Miyamoto M; Miyamoto T; Hirata K
    Parkinsonism Relat Disord; 2014 Feb; 20(2):212-6. PubMed ID: 24280021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High beta-adrenoceptor density on peripheral blood mononuclear cells in progressive multiple sclerosis: a manifestation of autonomic dysfunction?
    Zoukos Y; Thomaides T; Mathias CJ; Cuzner ML
    Acta Neurol Scand; 1994 Dec; 90(6):382-7. PubMed ID: 7892755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia.
    Kanazawa M; Tada M; Onodera O; Takahashi H; Nishizawa M; Shimohata T
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1149-51. PubMed ID: 23916652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone response to clonidine in central and peripheral primary autonomic failure.
    Thomaides TN; Chaudhuri KR; Maule S; Watson L; Marsden CD; Mathias CJ
    Lancet; 1992 Aug; 340(8814):263-6. PubMed ID: 1353191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.